Fifth Lane Capital’s Nu Skin NUS Stock Holding History

Fifth Lane Capital’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,189	Closed	-$162K	–	336
2021 Q4	$162K	Buy	+3,189	New	+$142K	0.1%	168

Other funds holding NUS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Fifth Lane Capital's NUS Position: Q1 2022 in Review

Fifth Lane Capital sold out of Nu Skin (NUS) in Q1 2022, closing a stake of 3,189 shares — an estimated $162K sold.

Fifth Lane Capital first reported a position in NUS in Q4 2021 and held it in 1 quarter. The position peaked at $162K in Q4 2021. 238 funds tracked by Wall St. Rank hold NUS as of Q1 2022.

Fifth Lane Capital reported no remaining Nu Skin position as of Q1 2022 after selling out during the quarter.
Fifth Lane Capital sold 3,189 Nu Skin shares in Q1 2022, an estimated $162K.
Fifth Lane Capital first reported a position in Nu Skin in Q4 2021 and held it in 1 quarter.
Fifth Lane Capital's Nu Skin position peaked at $162K in Q4 2021.
238 funds tracked by Wall St. Rank held Nu Skin as of Q1 2022.

Based on Fifth Lane Capital's 13F filing for Q1 2022, filed 16 May 2022.